Zdrowie i gospodarka · 30/12/2013

FDA Reclassifies Intra-Aortic Balloon Devices for Acute Coronary Syndrome and Septic Shock

The FDA is reclassifying intra-aortic balloon and control system devices for certain medical conditions, requiring premarket approval for septic shock and pulsatile flow generation, and updating the regulatory framework for these devices.